Clinical Features of and Antibiotic Resistance in Recurrent Urinary Tract Infection in Children with Vesicoureteral Reflux
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose: This study aimed to investigate the clinical features of recurrent urinary tract infection (UTI) in children with vesicoureteral reflux (VUR) and to compare the causative uropathogen and antibiotic susceptibility between the first and recurrent UTI episodes. Methods: We retrospectively reviewed the medical records of children with VUR who had recurrent UTI. Group 1 included patients in whom the same pathogen caused the first and recurrent UTI episodes. Group 2 included patients in whom different pathogens caused the first and recurrent UTI episodes. Results: During a 13-year study period (2005–2018), 77 children with VUR experienced at least one episode of UTI. Among these, 47 patients (61.0%) had recurrent UTI. Of the children with recurrent UTI, 19 (40.4%) were in group 1 and 28 (59.6%) were in group 2. Escherichia coli was the most commonly isolated uropathogen (n=37; 39.4%) in both episodes of recurrent UTIs, followed by Klebsiella pneumoniae (n=18; 19.1%), Enterococcus faecalis (n=14; 14.9%), and Enterobacter aerogenes (n=7; 7.4%). Although the difference was not significant, the rate of resistance to the antibiotics ceftazidime, piperacillin/tazobactam, and trimethoprim-sulfamethoxazole increased in patients with the second episode of E. coli recurrence in group 1, and that to cefotaxime, ceftazidime, piperacillin/tazobactam, and meropenem increased in children with the second episode of E. aerogenes recurrence in group 1. Conclusions: When selecting empirical antibiotics for recurrent UTI in children with VUR, it is important to consider that the pathogen and antimicrobial susceptibility of the previous UTI are not always the same in recurrent UTIs.
Abstract
Purpose: This study aimed to investigate the clinical features of recurrent urinary tract infection (UTI) in children with vesicoureteral reflux (VUR) and to compare the causative uropathogen and antibiotic susceptibility between the first and recurrent UTI episodes. Methods: We retrospectively reviewed the medical records of children with VUR who had recurrent UTI. Group 1 included patients in whom the same pathogen caused the first and recurrent UTI episodes. Group 2 included patients in whom different pathogens caused the first and recurrent UTI episodes. Results: During a 13-year study period (2005–2018), 77 children with VUR experienced at least one episode of UTI. Among these, 47 patients (61.0%) had recurrent UTI. Of the children with recurrent UTI, 19 (40.4%) were in group 1 and 28 (59.6%) were in group 2. Escherichia coli was the most commonly isolated uropathogen (n=37; 39.4%) in both episodes of recurrent UTIs, followed by Klebsiella pneumoniae (n=18; 19.1%), Enterococcus faecalis (n=14; 14.9%), and Enterobacter aerogenes (n=7; 7.4%). Although the difference was not significant, the rate of resistance to the antibiotics ceftazidime, piperacillin/tazobactam, and trimethoprim-sulfamethoxazole increased in patients with the second episode of E. coli recurrence in group 1, and that to cefotaxime, ceftazidime, piperacillin/tazobactam, and meropenem increased in children with the second episode of E. aerogenes recurrence in group 1. Conclusions: When selecting empirical antibiotics for recurrent UTI in children with VUR, it is important to consider that the pathogen and antimicrobial susceptibility of the previous UTI are not always the same in recurrent UTIs.
참고문헌 (28)
- Skoog SJ, "Pediatric vesicoureteral reflux guidelines panel summary report : clinical practice guidelines for screening siblings of children with vesicoureteral reflux and neonates", infants with prenatal hydronephrosis, 2010, pp.184, 1145~1151
- Younis N, "Antibiotic resistance in children with recurrent or complicated urinary tract infection", JNMA J Nepal Med Assoc, 48, pp.14~19 (2009)
- Lu KC, "Is combination antimicrobial therapy required for urinary tract infection in children?", J Microbiol Immunol Infect, 36, pp.56~60 (2003)
- Zorc JJ, "Diagnosis and management of pediatric urinary tract infections", Clin Microbiol Rev, 18, pp.417~422 (2005)
- Downs SM, "Technical report: urinary tract infections in febrile infants and young children. The Urinary Tract Subcommittee of the American Academy of Pediatrics Committee on Quality Improvement", Pediatrics, 103, pp.e54~ (1999)
- Hoberman A, "Imaging studies after a first febrile urinary tract infection in young children", N Engl J Med, 348, pp.195~202 (2003)
- Jerardi KE, "Nelson textbook of pediatrics", pp.2789~2795 (2020), Elsevier Inc
- RIVUR Trial Investigators, "Antimicrobial prophylaxis for children with vesicoureteral reflux", N Engl J Med, 370, pp.2367~2376 (2014)
- Lebowitz RL, "International system of radiographic grading of vesicoureteric reflux. International reflux study in children", Pediatr Radiol, 15, pp.105~109 (1985)
- Aydin A, "Recurrent urinary tract infections in women", Int Urogynecol J, 26, pp.795~804 (2015)
- Clinical and Laboratory Standards Institute, "Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard—eighth edition. CLSI document M07-A10", Clinical and Laboratory Standards Institute, 1~65 (2009)
- Chand DH, "Incidence and severity of vesicoureteral reflux in children related to age, gender, race and diagnosis", J Urol, 170, pp.1548~1550 (2003)
- 장현찬, "Primary Vesico-Ureteral Reflux: Comparison of Factors between Infants and Children", Investigative and Clinical Urology, 52(3), pp.206~209 (2011), 대한비뇨의학회
- Montini G, "Prophylaxis after first febrile urinary tract infection in children? A multicenter, randomized, controlled, noninferiority trial", Pediatrics, 122, pp.1064~1071 (2008)
- Roussey-Kesler G, "Antibiotic prophylaxis for the prevention of recurrent urinary tract infection in children with low grade vesicoureteral reflux : results from a prospective randomized study", J Urol, 179, pp.674~679 (2008)
- Dias CS, "Risk factors for recurrent urinary tract infections in a cohort of patients with primary vesicoureteral reflux", Pediatr Infect Dis J, 29, pp.139~144 (2010)
- Park S, "Bacterial pathogens in first febrile urinary tract infection affect breakthrough infections in infants with vesicoureteral reflux treated with prophylactic antibiotics", Urology, 81, pp.1342~1345 (2013)
- Shim YH, "The risk factors of recurrent urinary tract infection in infants with normal urinary systems", Pediatr Nephrol, 24, pp.309~312 (2009)
- Wu TH, "Treatment of recurrent complicated urinary tract infections in children with vesicoureteral reflux", J Microbiol Immunol Infect, 49, pp.717~722 (2016)
- Lange K, "Effects of antibiotics on gut microbiota", Dig Dis, 34, pp.260~268 (2016)
- Becattini S, "Antibiotic-induced changes in the intestinal microbiota and disease", Trends Mol Med, 22, pp.458~478 (2016)
- Soto SM, "Importance of biofilms in urinary tract infections : new therapeutic approaches", Adv Biol, 2014, pp.543974~ (2014)
- Sanchez CJ Jr, "Biofilm formation by clinical isolates and the implications in chronic infections", BMC Infect Dis, 13, pp.47~ (2013)
- Hooton TM, "Pathogenesis of urinary tract infections : an update", J Antimicrob Chemother, 46(Suppl A), pp.1~7 (2000)
- Jantunen ME, "Recurrent urinary tract infections in infancy: relapses or reinfections?", J Infect Dis, 185, pp.375~379 (2002)
- Russo TA, "Chromosomal restriction fragment length polymorphism analysis of Escherichia coli strains causing recurrent urinary tract infections in young women", J Infect Dis, 172, pp.440~445 (1995)
- Foxman B, "Virulence characteristics of Escherichia coli causing first urinary tract infection predict risk of second infection", J Infect Dis, 172, pp.1536~1541 (1995)
- Craig JC, "Antibiotic prophylaxis and recurrent urinary tract infection in children", N Engl J Med, 361, pp.1748~1759 (2009)